Cambridge Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $97.7K | Sell |
181
-191
| -51% | -$104K | ﹤0.01% | 350 |
|
|
2023
Q4 | $206K | Hold |
372
| – | – | 0.01% | 261 |
|
|
2023
Q3 | $163K | Sell |
372
-9
| -2% | -$4.49K | 0.01% | 283 |
|
|
2023
Q2 | $191K | Sell |
381
-1
| -0.3% | -$479 | 0.01% | 277 |
|
|
2023
Q1 | $191K | Sell |
382
-13
| -3% | -$6.22K | 0.01% | 279 |
|
|
2022
Q4 | $161K | Sell |
395
-37
| -9% | -$14.4K | 0.01% | 312 |
|
|
2022
Q3 | $141K | Sell |
432
-20
| -4% | -$7.35K | 0.01% | 320 |
|
|
2022
Q2 | $158K | Sell |
452
-1,094
| -71% | -$446K | 0.01% | 327 |
|
|
2022
Q1 | $846K | Buy |
1,546
+913
| +144% | +$480K | 0.03% | 172 |
|
|
2021
Q4 | $416K | Buy |
633
+159
| +34% | +$99.8K | 0.01% | 245 |
|
|
2021
Q3 | $295K | Sell |
474
-8
| -2% | -$5.38K | 0.01% | 220 |
|
|
2021
Q2 | $304K | Sell |
482
-59
| -11% | -$32.6K | 0.01% | 218 |
|
|
2021
Q1 | $265K | Sell |
541
-50
| -8% | -$25.1K | 0.01% | 232 |
|
|
2020
Q4 | $295K | Sell |
591
-40
| -6% | -$17.9K | 0.01% | 193 |
|
|
2020
Q3 | $248K | Sell |
631
-54
| -8% | -$20K | 0.01% | 204 |
|
|
2020
Q2 | $267K | Buy |
+685
| New | +$198K | 0.01% | 204 |
|
|
2019
Q3 | – | Sell |
-750
| Closed | -$206K | – | 263 |
|
|
2019
Q2 | $206K | Buy |
+750
| New | +$185K | 0.01% | 249 |
|
|
2019
Q1 | – | Sell |
-1,300
| Closed | -$242K | – | 248 |
|
|
2018
Q4 | $242K | Sell |
1,300
-100
| -7% | -$20.5K | 0.02% | 217 |
|
|
2018
Q3 | $350K | Sell |
1,400
-100
| -7% | -$24.3K | 0.02% | 201 |
|
|
2018
Q2 | $327K | Hold |
1,500
| – | – | 0.02% | 204 |
|
|
2018
Q1 | $287K | Sell |
1,500
-136
| -8% | -$25.1K | 0.02% | 219 |
|
|
2017
Q4 | $256K | Hold |
1,636
| – | – | 0.02% | 228 |
|
|
2017
Q3 | $254K | Hold |
1,636
| – | – | 0.02% | 230 |
|
|
2017
Q2 | $264K | Sell |
1,636
-7,100
| -81% | -$1.15M | 0.02% | 222 |
|
|
2017
Q1 | $1.35M | Hold |
8,736
| – | – | 0.09% | 122 |
|
|
2016
Q4 | $1.02M | Hold |
8,736
| – | – | 0.07% | 126 |
|
|
2016
Q3 | $985K | Hold |
8,736
| – | – | 0.07% | 127 |
|
|
2016
Q2 | $811K | Buy |
+8,736
| New | +$750K | 0.06% | 136 |
|
|
2016
Q1 | – | Sell |
-2,872
| Closed | -$210K | – | 235 |
|
|
2015
Q4 | $210K | Sell |
2,872
-297
| -9% | -$21.2K | 0.02% | 207 |
|
|
2015
Q3 | $235K | Buy |
+3,169
| New | +$227K | 0.02% | 192 |
|
Other funds holding IDXX
Cambridge Trust's IDXX Position: Q1 2024 in Review
Cambridge Trust reduced its Idexx Laboratories (IDXX) stake by 51% in Q1 2024, selling an estimated $104K and leaving 181 shares worth $97.7K. The position accounts for ﹤0.01% of the portfolio, ranked #350.
Cambridge Trust first reported a position in IDXX in Q3 2015 and has held it in 30 quarters since. The position peaked at $1.35M in Q1 2017. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.
- Cambridge Trust held 181 shares of Idexx Laboratories worth $97.7K as of Q1 2024.
- Cambridge Trust sold 191 Idexx Laboratories shares in Q1 2024, an estimated $104K.
- Idexx Laboratories made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #350 holding.
- Cambridge Trust first reported a position in Idexx Laboratories in Q3 2015 and has held it in 30 quarters since.
- Cambridge Trust's Idexx Laboratories position peaked at $1.35M in Q1 2017.
- 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.